Objective: To determine the efficacy and safety of percutaneous aspiration and steroid injection treatment for ganglion cysts and retrospectively evaluate the size change in ganglion cysts during follow-up.
Material and Method: All patients who underwent percutaneous aspiration and steroid injection treatment for ganglion cysts between January 2019 and February 2020 were included in the study. Demographic characteristics and clinical signs and findings of the patients were obtained from electronic patient records. Treatment response was classified as “excellent,” “good,” and “poor” at one month and one year according to ultrasound measurement.
Results: Ganglion cyst aspiration and steroid injection were successfully performed in 37 (86.0%) of 43 cases. A total of 28 cases with short- and long-term follow-ups were included in the final analysis. All the cases had cosmetic complaints before the treatment, and seven had pain and four had limited range of motion. Early treatment response was excellent in 7 (25.0%) patients, good in 14 (50.0%), and poor in 7 (50.0%). Late treatment response was excellent in 18 (64.3%) patients, good in 3 (10.7%), and poor in 7 (25.0%). After the procedure, mild pain lasting less than two days developed in the cyst area in half of the patients. Skin color change was observed in two cases in the first-month follow-up.
Conclusion: Ultrasound-guided fine-needle aspiration and steroid injection with the right technique is an alternative cost-effective method to surgery that can be successfully applied in the treatment of ganglion cysts with low side effects and relatively good results.
N/A
N/A
N/A
Birincil Dil | İngilizce |
---|---|
Konular | Sağlık Kurumları Yönetimi |
Bölüm | Orijinal Makale |
Yazarlar | |
Proje Numarası | N/A |
Yayımlanma Tarihi | 17 Ocak 2022 |
Yayımlandığı Sayı | Yıl 2022 |
Üniversitelerarası Kurul (ÜAK) Eşdeğerliği: Ulakbim TR Dizin'de olan dergilerde yayımlanan makale [10 PUAN] ve 1a, b, c hariç uluslararası indekslerde (1d) olan dergilerde yayımlanan makale [5 PUAN]
Dahil olduğumuz İndeksler (Dizinler) ve Platformlar sayfanın en altındadır.
Not: Dergimiz WOS indeksli değildir ve bu nedenle Q olarak sınıflandırılmamıştır.
Yüksek Öğretim Kurumu (YÖK) kriterlerine göre yağmacı/şüpheli dergiler hakkındaki kararları ile yazar aydınlatma metni ve dergi ücretlendirme politikasını tarayıcınızdan indirebilirsiniz. https://dergipark.org.tr/tr/journal/2316/file/4905/show
Dergi Dizin ve Platformları
Dizinler; ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, vs.
Platformlar; Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons vs.